- Home
- TLPH vs PTHL Comparison
TLPH vs PTHL Comparison
Compare TLPH & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLPH
- PTHL
- Stock Information
- Founded
- TLPH 2005
- PTHL 1998
- Country
- TLPH United States
- PTHL China
- Employees
- TLPH N/A
- PTHL N/A
- Industry
- TLPH Biotechnology: Pharmaceutical Preparations
- PTHL
- Sector
- TLPH Health Care
- PTHL
- Exchange
- TLPH Nasdaq
- PTHL Nasdaq
- Market Cap
- TLPH 11.1M
- PTHL 10.0M
- IPO Year
- TLPH 2011
- PTHL 2024
- Fundamental
- Price
- TLPH $1.25
- PTHL $0.61
- Analyst Decision
- TLPH Strong Buy
- PTHL
- Analyst Count
- TLPH 1
- PTHL 0
- Target Price
- TLPH $6.00
- PTHL N/A
- AVG Volume (30 Days)
- TLPH 480.8K
- PTHL 103.3K
- Earning Date
- TLPH 11-12-2025
- PTHL 01-01-0001
- Dividend Yield
- TLPH N/A
- PTHL N/A
- EPS Growth
- TLPH N/A
- PTHL N/A
- EPS
- TLPH N/A
- PTHL N/A
- Revenue
- TLPH $27,000.00
- PTHL $448,196.00
- Revenue This Year
- TLPH N/A
- PTHL N/A
- Revenue Next Year
- TLPH $14,533.26
- PTHL N/A
- P/E Ratio
- TLPH N/A
- PTHL N/A
- Revenue Growth
- TLPH N/A
- PTHL N/A
- 52 Week Low
- TLPH $0.38
- PTHL $0.51
- 52 Week High
- TLPH $1.45
- PTHL $32.00
- Technical
- Relative Strength Index (RSI)
- TLPH 64.99
- PTHL 31.54
- Support Level
- TLPH $1.12
- PTHL $0.58
- Resistance Level
- TLPH $1.19
- PTHL $0.67
- Average True Range (ATR)
- TLPH 0.11
- PTHL 0.05
- MACD
- TLPH -0.01
- PTHL 0.06
- Stochastic Oscillator
- TLPH 59.83
- PTHL 31.66
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.